CoChat

Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study

The DOI matches its Crossref record, with a small difference in title or year; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Treatment strategies against acute neuroleptic-induced akathisia (NIA) include anticholinergic (antimuscarinic) agents, dopamine agonists, GABAergic agents, beta-blockers, benzodiazepines, and serotonin antagonists. However, many patients who have acute akathisia fail to respond. In previous studies, mianserin and vitamin B6 were found to be effective in the treatment of acute akathisia. The purpose of this study was to compare the efficacy of B(6), mianserin and placebo in the treatment of acute NIA. Sixty schizophrenia and schizoaffective inpatients who have NIA were randomly divided to receive vitamin B(6) 1,200 mg/d, mianserin 15 mg/d, or placebo for 5 days, in a double-blind design. The Barnes Akathisia Rating Scale, Brief Psychiatric Rating Scale, and Clinical Global Impression were used to assess the severity of NIA and psychotic symptoms. The assessment was made at baseline and daily for the duration of the study. Compared with the placebo group, the vitamin B(6)-treated and mianserin-treated patients showed a significant improvement in the subjective (P < 0.0001), subjective distress (P < 0.0001), and global (P < 0.0001) subscales. The objective subscale did not show significant positive results (P = 0.056), but there was a trend toward symptom amelioration in both groups. A reduction of at least 2 points on the Barnes Akathisia Rating Scale global subscale was noted in the vitamin B(6) group (13/23, 56%) as well as in the mianserin groups (13/20, 65%), and in only one patient in the placebo group (1/17, 6%; P < 0.0005). Our results indicate that high doses of B(6) and a low dose of mianserin may be a useful addition to current treatments of NIA. The efficacy of vitamin B(6) and mianserin suggests that the pathophysiology of acute NIA is heterogeneous with the various subtypes of acute NIA responding differently to the various pharmacological approaches.

Overview

Integrity signals

Registry

Crossref · 10.1097/00002826-200603000-00002

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 8

  1. Poyurovsky, 1998, Isr J Psychiatry Relat Sci, 35, 70
  2. DeVeaugh-Geiss, 1978, J Clin Psychiatry, 39, 573
  3. Devaux, 1987, Semin Hop Paris, 63, 1476
  4. Lerner, 1999, Clin Neuropharmacol, 22, 241
  5. Holman, 1995, J Aust Coll Nutr Environ Med, 14, 5
  6. Cabrini, 1998, Biochem Mol Biol Int, 46, 689
  7. Miller, 1990, Psychopharmacol Bull, 26, 373
  8. Poyurovsky, 2003, J Clin Psychopharmacol, 23, 305

Cited by

See all 50

Metadata

Authors
Miodownik, C., Lerner, V., Statsenko, N., Dwolatzky, T., Nemets, B., Berzak, E., & Bergman, J.
Affiliations
Ben-Gurion University of the Negev (IL)
Corresponding author
  • Miodownik, Chanoch
  • Lerner, Vladimir
  • Statsenko, Nikolay
  • Dwolatzky, Tzvi
  • Nemets, Boris
  • Berzak, Elina
Venue
Clinical Neuropharmacology
Published
2006-03
Volume
29
Issue
2
Pages
68-72
ISSN
0362-5664 (ISSN-L)
OpenAlex
W2003451122
Cited by
47
References
32
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 7 · 2017: 2 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 1
FWCI
1.91
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
neuroleptic-induced akathisia, vitamin B6, mianserin, antipsychotic adverse effects, schizophrenia, schizoaffective disorder, serotonin antagonists, placebo comparison
MeSH terms
Acute Disease, Adrenergic alpha-Antagonists, Adult, Aged, Bipolar Disorder, Double-Blind Method, Female, Humans, Male, Mianserin, Middle Aged, Psychotic Disorders, Schizophrenia, Antipsychotic Agents, Vitamins, Akathisia, Drug-Induced, Vitamin B 6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study. https://app.cochat.ai/papers/10.1097/00002826-200603000-00002
The paper
Miodownik, C., Lerner, V., Statsenko, N., Dwolatzky, T., Nemets, B., Berzak, E., & Bergman, J. (2006). Vitamin B6 Versus Mianserin and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-200603000-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.